Sirolimus for Nosebleeds in HHT
Condition(s):Hereditary Hemorrhagic Telangiectasia; Nosebleeds; EpistaxisLast Updated:March 5, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Hereditary Hemorrhagic Telangiectasia; Nosebleeds; EpistaxisLast Updated:March 5, 2024Recruiting
Condition(s):Peripheral NeuropathyLast Updated:March 27, 2023Completed
Condition(s):AsthmaLast Updated:February 26, 2013Unknown status
Condition(s):Diabetes Mellitus, Type 2; Type 2 Diabetes Mellitus; Periodontal Diseases; Periodontitis; Chronic PeriodontitisLast Updated:May 4, 2018Completed
Condition(s):Ischemic Stroke; Adipose Tissue-derived Stem Cell; Functional StatusLast Updated:May 30, 2023Recruiting
Condition(s):Covid19; Angiogenesis; Endothelial Dysfunction; Cardiovascular MorbidityLast Updated:July 25, 2023Completed
Condition(s):FibromyalgiaLast Updated:April 11, 2017Completed
Condition(s):Thin EndometriumLast Updated:July 13, 2022Completed
Condition(s):Locally Advanced Rectal Cancer; Abdominoperineal Resection; InfectionLast Updated:April 3, 2023Completed
Condition(s):Incompatible Blood Transfusion; Immune Defect; SurgeryLast Updated:September 8, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.